Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Proposed Mechanisms of BPC-157 Animal and laboratory data suggest that BPC-157 may: Stimulate angiogenesis , promoting new blood vessel formation to improve nutrient delivery to injured tissues
Several Substances Get Placed on the Category 2 Bulks List The following substances were added to Category 2 because FDA claimed to identify significant safety risks: AOD 9604 BPC-157 Cathelicidin LL-37 CJC-1295 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) Ibutamoren Mesylate Ipamorelin Acetate Kisspeptin-10 KPV Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF) MOTs-C Selank Acetate (TP-7) Semax (heptapeptide) Thymosin Alpha-1 (Ta1) Thymosin Beta-4, Fragment (LKKTETQ) Compounding Industry Group Initial Response In early October, Scott Brunner from the Alliance for Pharmacy Compounding (APC) commented on the updates, particularly noting the addition of certain peptides to Category 2
What It Is This blend combines BPC-157 peptide, a synthetic fragment of a gastric protective protein, with TB-500, a synthetic analog of thymosin beta-4 that naturally regulates cellular structure and movement
Each system is designed so the peptides work together, amplifying each other's results
